Reconsidering the management of palpable DCIS: a single institution audit
Background: Ductal carcinoma in situ (DCIS) identified by screening mammography accounts for 20% of breast cancer diagnoses, and microinvasion (DCIS-M) is found in 5% –10%. There are no defined treatment guidelines for palpable DCIS or DCIS-M. The role of screening mammography is now being questioned across the world and in the developing world with no national screening programs, women with DCIS present with a palpable lump in the breast. We conducted a retros pective audit of women with DCIS treated at our institution to classify palpable DCIS and DCIS-M as distinct clinical stages and emphasize the need for a change in management of ‘palpable DCIS’.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: N. Nair, K. Kirti, T. Shet, R. Hawaldar, V. Parmar, S. Gulia, S. Joshi, S. Murali, V. Vanmali, B. Bandare, S. Gupta, R. Badwe Tags: POSTERS A: Optimal Diagnosis Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Mammography | Women